iHerb Expands Consumer Benefits Across Asia with 618 Shopping Festival 
Trade Compliance Records Addresses June 2026 Executive Order Broker Liability 
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth 
Central Asia visit drives multi-sector collaboration, Business delegation signed 66 MoUs and agreements to seize Belt and Road opportunities 
Custom Health Holdings Inc. Announces Completion of Plan of Arrangement Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to…
Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series
– Toripalimab plus chemotherapy met both primary endpoint of progression free survival and prespecified secondary…
Kamada Issues 2022 CEO Letter to Shareholders
REHOVOT, Israel, March 15, 2022 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a…
Burning Rock to Release MRD Clinical Data on NSCLC and CRC at the Upcoming American Association for Cancer Research Annual Meeting
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Altimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
Data readouts from multiple clinical trials expected during the next 6 to 12 months Strong…
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed…
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
On track for top-line data in April 2022 WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE)…
Nabriva Therapeutics to Report 2021 Financial Results and Recent Corporate Highlights on March 29, 2022
DUBLIN, Ireland and FORT WASHINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
Entrada Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
On track to submit IND application for ENTR-601-44 targeting Duchenne muscular dystrophy in 2H 2022…
Kane Biotech Announces Private Placement Offering
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG,…
Imara Reports Full Year 2021 Financial Results and Business Highlights
Completed enrollment in Phase 2b sickle cell disease and beta-thalassemia trials with tovinontrine (IMR-687); expect…
Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
– Presented positive initial dose-escalation clinical data for SL-172154, including high target occupancy, dose-dependent immune…
Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
LOS ANGELES, March 15, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — Enochian BioSciences, a company focused…
Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
APEX, SUMMIT and PEAK bezuclastinib clinical trials actively enrolling patients APEX initial clinical data presentation…
Krystal Biotech Announces Settlement with PeriphaGen, Inc.
PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Kamada Reports Fiscal Year and Fourth Quarter 2021 Financial Results; Provides Revenue and Profitability Guidance with Significant Growth Expected in 2022
Total Revenues for Fiscal Year 2021 were $103.6 Million and Fourth Quarter 2021 Revenues were…
ASLAN Pharmaceuticals Appoints Dermatology Veteran Dr Alex Kaoukhov as Chief Medical Officer
– Dermatologist with over twenty years of experience in senior biopharma roles in the US…
Todos Medical to Present at the Emerging Growth Conference
– Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST – New York,…
Roche Annual General Meeting 2022
All proposals of the Board of Directors approved Christoph Franz as Chairman of the Roche…
23andMe to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
SUNNYVALE, Calif., March 15, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a…